Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Believes Size Matters In Amyloidosis

The Big Pharma explains its eplontersen strategy

18 Sep 2024

• By Elizabeth Cairns

AstraZeneca

Related Content

AZ And Boehringer Move Into Phase III With Rival Next-Gen CKD Drugs

06 Nov 2023

AstraZeneca Nabs CinCor’s Hypertension Asset In $1.3bn Acquisition

10 Jan 2023

ESC: Alnylam’s Aim For First-Line Amvuttra Use Looks Dicey

30 Aug 2024

Related Companies

Alnylam Pharmaceuticals Inc.

Ionis Pharmaceuticals, Inc.

AstraZeneca PLC

Pfizer Inc.

BridgeBio Pharma, Inc.

Additional Topics

Commercial Leadership Companies Clinical Trials Research & Development Cardiovascular Renal BioPharmaceutical

More from Leadership

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.